Regulation of MLL/COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia.
Zhao, Z; Wang, L; Volk, AG; Birch, NW; Stoltz, KL; Bartom, ET; Marshall, SA; Rendleman, EJ; Nestler, CM; Shilati, J; et al.
Genes and Development.
2019;
33:61-74.
USP7 cooperates with NOTch1 to drive the oncogenic transcriptional program in T-cell leukemia.
Jin, Q; Martinez, CA; Arcipowski, KM; Zhu, Y; Gutierrez-Diaz, BT; Wang, KK; Johnson, MR; Volk, AG; Wang, F; Wu, J; et al.
Clinical Cancer Research.
2019;
25:222-239.
A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis.
Volk, A; Liang, K; Suraneni, P; Li, X; Zhao, J; Bulic, M; Marshall, S; Pulakanti, K; Malinge, S; Taub, J; et al.
Cancer Cell.
2018;
34:707-723.e7.
Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway.
Xin, J; You, D; Breslin, P; Li, J; Wei, W; Cannova, J; Volk, A; Gutierrez, R; Xiao, Y; Ni, A; et al.
Leukemia.
2017;
31:1154-1165.
Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia.
Liang, K; Volk, AG; Haug, JS; Marshall, SA; Woodfin, AR; Bartom, ET; Gilmore, JM; Florens, L; Washburn, MP; Sullivan, KD; et al.
Cell.
2017;
31:59-72.e13.
Not All H3K4 Methylations Are Created Equal: Mll2/COMPASS Dependency in Primordial Germ Cell Specification.
Hu, D; Gao, X; Cao, K; Morgan, MA; Mas, G; Smith, ER; Volk, AG; Bartom, ET; Crispino, JD; Di Croce, L; et al.
Molecular Cell.
2017;
65:460-475.e6.
Sensitizing leukemia stem cells to NF-kappa B inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling.
Li, J; Volk, A; Zhang, J; Cannova, J; Dai, S; Hao, C; Hu, C; Sun, J; Xu, Y; Wei, W; et al.
Oncotarget.
2017;
8:8420-8435.
Hematopoietic Stem Cell Activity Is Regulated by Pten Phosphorylation Through a Niche-Dependent Mechanism.
Li, J; Zhang, J; Tang, M; Xin, J; Xu, Y; Volk, A; Hao, C; Hu, C; Sun, J; Wei, W; et al.
Stem Cells.
2016;
34:2130-2144.